Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure-affinity investigation

European Journal of Medicinal Chemistry

Volumn 31, Issue 11, 1996, Pages 875-888

  Dukat, M ^b   Fiedler, W ^b   Dumas, D ^b   Damaj, I ^a   Martin, B R ^a   Rosecrans, J A ^a   James, J R ^a   Glennon, R A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Antinociception; Drug discrimination; Nicotine; Nicotine receptor

Indexed keywords

EPIBATIDINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DRUG DISCRIMINATION; DRUG RECEPTOR BINDING; HYPERACTIVITY; LOCOMOTION; MOUSE; NONHUMAN; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029801534     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)89850-9     Document Type: Article

References (64)

1. 1 Stolerman I, Shoaib M (1991) Trends Pharmacol Sci 12, 467-473
2. 2 Palmer KJ, Buckley MM, Faulds D (1992) Drugs 44, 498-529
3. 3 Rosecrans J, Levin E, Karan L (1993) Med Chem Res 2, 505-508
4. 4 Levin ED, Rosecrans JA (1994) Drug Dev Res 31, 1-3
5. 5 William M, Sullivan JP, Arneric SP (1994) Drug News Perspect 7, 205-223
6. 6 Barlow RB, Hamilton JT (1962) Br J Pharmacol 18, 510-542
7. 7 Haglid F (1967) Acta Pharm Suec 4, 117-138
8. 8 Rondahl L (1976) Acta Pharm Suec 13, 229-234
9. 9 Glennon RA, Maarouf A, Fahmy S et al (1993) Med Chem Res 2, 546-551
10. 10 Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A (1985) J Neurosci 5, 1307-1315
11. 11 Deneris ES, Connolly J, Rogers SW, Duvoisin R (1991) Trends Pharmacol Sci 12, 34-40
12. 12 Sheridan RP, Nilakantan R, Dixon JS, Venkataraghaven (1986) J Med Chem 29, 899-906
13. 13 Lin N-H, Carrera G M, Anderson DJ (1994) J Med Chem 37, 3542-3553
14. 14 Dukat M, Damaj MI, Glassco W et al (1993) Med Chem Res 4, 131-139
15. 15 Shibagaki M, Tsujino Y, Matsushita H, Kameko H (1987) Japanese patent, Jpn Kokai Tokyo Koho 6 281 381; Chem Abstr (1988) 108, 132139k; Chem Abstr (1988), 108, 5858u
16. Shibagaki M, Tsujino Y, Matsushita H, Kameko H (1987) Japanese patent, Jpn Kokai Tokyo Koho 6 281 381; Chem Abstr (1988) 108, 132139k; Chem Abstr (1988), 108, 5858u
17. Shibagaki M, Tsujino Y, Matsushita H, Kameko H (1987) Japanese patent, Jpn Kokai Tokyo Koho 6 281 381; Chem Abstr (1988) 108, 132139k; Chem Abstr (1988), 108, 5858u
18. 16 Shibagaki M, Matsushita H, Kaneko H (1986) Heterocycles 24, 2315-2319
19. 17 Borch RF, Bernstein MD, Durst HD (1971) J Am Chem Soc 93, 2897-2904
20. 18 Sattler HJ, Schunack W (1975) Chem Ber 108, 730-734
21. 19 Armarego WLF, Milloy BA, Sharma SC (1971) J Chem Soc, Perkin Trans 1, 2485-2490
22. 20 Danieli R, Ricci A (1973) Synthesis 46-47
23. 21 Jutz C, Mueller W, Mueller E (1966) Chem Ber 99, 2479-2490
24. 22 Ikekawa N (1958) Pharm Bull 6, 408-411
25. 23 Catka TE, Leete E (1978) J Org Chem 43, 2125-2127
26. 24 Seeman JI, Secor HV, Chavdarian CG, Sanders EB, Bassfield RL, Whidby JF (1981) J Org Chem 46, 3040-3048
27. 25 Leete E, Leete SAS (1978) J Am Chem Soc 43, 2122-2125
28. 26 Glassco W, May EL, Damaj MI, Martin BR (1994) Med Chem Res 4, 273-282
29. 27 Glassco W, Suchocki J, George C, Martin BR, May EL (1993) J Med Chem 36, 3381-3385
30. 28 Fromherz K, Spiegelberg H (1948) Helv Physiol Pharmacol Acta 6, 42-54
31. 29 Erdtman H, Haglid F, Wellings I, von Euler US (1963) Acta Chem Scand 17, 1717-1726
32. 30 Haglid F, Wellings I (1963) Acta Chem Scand 17, 1727-1734
33. 31 Rosecrans JA, Spenser RM, Krynock GM, Chance WT (1978) In: Behavioral Effects of Nicotine (Battig K, ed) Karger, Basel, 70-82
34. 32 Kamimura H, Matsumoto A, Miyazaki Y, Yamamoto I (1963) Agric Biol Chem 27, 684-688
35. 33 Soeda Y, Yamamoto I (1968) Agric Biol Chem 32, 747-752
36. 34 Work TS (1942) J Chem Soc Lond 429-432
37. 35 Uffer A, Schlittler E (1948) Helv Chim Acta 31, 1397-1400
38. 36 Sam J, Minor WF (1959) J Am Chem Soc 81, 710-713
39. 37 Secor HV, Edwards WB (1979) J Org Chem 44, 3136-3140
40. 38 Abood LG, Lu X, Banerjee S (1987) Biochem Pharmacol 36, 2337-2341
41. 39 Glennon RA, Herndon JL, Dukat M (1994) Med Chem Res 4, 461-473
42. 40 Pitner TP, Edwards WB, Bassfield RL, Whidby JF (1978) J Am Chem Soc 100, 246-251
43. 41 Whidby JF, Seeman JI (1976) J Org Chem 41, 1585-1590
44. 42 Wonnacott S (1987) Human Toxicol 6, 343-353
45. 43 Glassco W, May EL, Weaver V, Damaj MI, Rosecrans JA, Martin BR (1994) Med Chem Res 4, 474-482
46. 44 Rogers DT, Iwamoto ET (1993) J Pharmacol Exp Ther 267, 341-349
47. 45 Juma I, Krauss I, Baldauf J (1993) Clin Investig 72, 65-73
48. 46 Damaj MI, Welch SP, Martin BR (1993) J Pharmacol Exp Ther 266, 1330-1338
49. 47 Damaj MI, Glennon RA, Martin BR (1994) Brain Res Bull 33, 199-203
50. 48 Rosecrans JA (1989) J Subst Abuse 1, 287-300
51. 49 Spande TF, Garraffo HM, Edwards MW, Yeh JC, Pannell L, Daly JW (1992) J Am Chem Soc 114, 3475-3478
52. 50 Dukat M (1994) Med Chem Res 4, 433-439
53. 51 Wypij DM, Shen TY (1994) In: International Synposium on Nicotine: The Effects of Nicotine on Biological Systems (Clarke PBS, Quik M, Thurau K, Adlkofer F, eds) Birkhauser, Basel, Abstract P32
54. 52 Comins DL, Killpack MO (1990) J Org Chem 55, 69-73
55. 53 Bobbitt JM, Scola DA (1960) J Org Chem 25, 560-564
56. 54 Shiozawa A, Ichikawa Y-I, Ishikawa M et al (1984) Chem Pharm Bull 32, 2522-2529
57. 55 Berg-Nielsen K, Skattebol L (1978) Acta Chem Scand B32, 553-556
58. 56 Thummel RP, Kohli DK (1977) J Org Chem 42, 2742-2747
59. 57 Haglid F (1967) Ark Kemi 26, 489-495
60. 58 Caprathe BW, Jaen JC, Wise LD et al (1991) J Med Chem 34, 2736-2746
61. 59 Scimeca JA, Martin BR (1988) J Pharm Pharmacol 40, 793-797
62. 60 Munson PJ, Rodbard D (1980) Anal Biochem 107, 220-239
63. 61 Cheng YC, Prusoff WH (1973) Biochem Pharmacol 22, 3099-3108
64. 62 Dewey WL, Harris LS, Howes JS, Nuite JA (1970) J Pharmacol Exp Ther 175, 435-442